The Council for Scientific and Industrial Research on October 25, 2015 launched the scientifically validated anti-diabetes herbal drug, named 'BGR-34', which is combination of natural extracts from plants, the drug is based on Ayurveda and has no side effects. The drug has been jointly developed by two CSIR laboratories, National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plant (CIMAP) for management of type-II diabetes mellitus.

While the formulation was launched earlier by Mr Hamid Ansari, vice president of India in February, 2014, the product has been launched commercially now.

Manufactured by New Delhi based Aimil Pharamaceuticals, it will be available in market shortly, will be available in the form of tablets priced at Rs 500 for 100 tablets, which means approximately Rs 5 per tablet. According to NBRI, the drug has been tested on animals and scientific study has found it safe and effective, with clinical trials showing 67 percent success.

The drug boosts immune system, works as antioxidant and checks free radicals. The drug will help maintain normal blood glucose levels, reduce chances of complications due to persistent high blood glucose levels and impart a good quality life to patients with high blood sugar levels.